Patents by Inventor Phoebe Chiang

Phoebe Chiang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pyrimidine compounds and methods of making and using same
    Patent number: 8513242
    Abstract: Disclosed herein are pyrimidinyl compounds that are contemplated to be modulators of cystic fibrosis transmembrane regulators (CFTR), and methods of making and using same. Also provided are pharmaceutical compositions and methods of treating disorders associated with cystic fibrosis transmembrane regulators, such as airway inflammation, cystic fibrosis, and the like.
    Type: Grant
    Filed: December 11, 2009
    Date of Patent: August 20, 2013
    Assignee: Cystic Fibrosis Foundation Therapeutics, Inc.
    Inventors: Phoebe Chiang, Shomir Ghosh
  • Pyrimidine compounds and methods of making and using same
    Patent number: 8334292
    Abstract: Disclosed herein are pyrimidinyl compounds that are contemplated to be modulators of cystic fibrosis transmembrane regulators (CFTR), and methods of making and using same. Also provided are pharmaceutical compositions and methods of treating disorders associated with cystic fibrosis transmembrane regulators, such as airway inflammation, cystic fibrosis, and the like.
    Type: Grant
    Filed: June 14, 2011
    Date of Patent: December 18, 2012
    Assignee: Cystic Fibrosis Foundation Therapeutics, Inc.
    Inventor: Phoebe Chiang
  • Pyrimidine Compounds and Methods of Making and Using Same
    Publication number: 20110281873
    Abstract: Disclosed herein are pyrimidinyl compounds that are contemplated to be modulators of cystic fibrosis transmembrane regulators (CFTR), and methods of making and using same. Also provided are pharmaceutical compositions and methods of treating disorders associated with cystic fibrosis transmembrane regulators, such as airway inflammation, cystic fibrosis, and the like.
    Type: Application
    Filed: December 11, 2009
    Publication date: November 17, 2011
    Inventors: Phoebe Chiang, Shomir Ghosh
  • 5-HT receptor ligands and uses thereof
    Patent number: 6995159
    Abstract: Compounds of Formula (IC) that act as 5-HT receptor ligands and their uses in the treatment of diseases linked to the activation of 5-HT2 receptors in animals are described herein .
    Type: Grant
    Filed: September 16, 2004
    Date of Patent: February 7, 2006
    Assignee: Pfizer Inc.
    Inventors: Phoebe Chiang, William A. Novomisle, Willard M. Welch, Jr.
  • 5-HT receptor ligands and uses thereof
    Patent number: 6894050
    Abstract: Compounds of Formula (IA) that act as 5-HT receptor ligands and their uses in the treatment of diseases linked to the activation of 5-HT2 receptors in animals are described herein
    Type: Grant
    Filed: June 5, 2002
    Date of Patent: May 17, 2005
    Assignee: Pfizer Inc.
    Inventors: Phoebe Chiang, William A. Novomisle, Willard M. Welch, Jr., Angel Guzman-Perez, Paul A. DaSilva-Jardine, Ravi S. Garigipati, Kevin K. Liu
  • 5-HT receptor ligands and uses thereof
    Publication number: 20050090503
    Abstract: Compounds of Formula (IA) that act as 5-HT receptor ligands and their uses in the treatment of diseases linked to the activation of 5-HT2 receptors in animals are described herein.
    Type: Application
    Filed: August 19, 2004
    Publication date: April 28, 2005
    Inventors: Phoebe Chiang, William Novomisle, Willard Welch, Angel Guzman-Perez, Paul DaSilva-Jardine, Ravi Garigipati, Kevin Liu
  • 5-HT receptor ligands and uses thereof
    Publication number: 20050054656
    Abstract: Compounds of Formula (IA) that act as 5-HT receptor ligands and their uses in the treatment of diseases linked to the activation of 5-HT2 receptors in animals are described herein.
    Type: Application
    Filed: September 16, 2004
    Publication date: March 10, 2005
    Inventors: Phoebe Chiang, William Novomisle, Willard Welch
  • 5-HT receptor ligands and uses thereof
    Publication number: 20050032809
    Abstract: Compounds of Formula (IA) that act as 5-HT receptor ligands and their uses in the treatment of diseases linked to the activation of 5-HT2 receptors in animals are described herein.
    Type: Application
    Filed: September 16, 2004
    Publication date: February 10, 2005
    Inventors: Phoebe Chiang, William Novomisle, Willard Welch
  • 5-HT receptor ligands and uses thereof
    Publication number: 20050020604
    Abstract: Compounds of Formula (IA) that act as 5-HT receptor ligands and their uses in the treatment of diseases linked to the activation of 5-HT2 receptors in animals are described herein.
    Type: Application
    Filed: August 19, 2004
    Publication date: January 27, 2005
    Inventors: Phoebe Chiang, William Novomisle, Willard Welch, Angel Guzman-Perez, Paul DaSilva-Jardine, Ravi Garigipati, Kevin Liu
  • 5-HT receptor ligands and uses thereof
    Patent number: 6825198
    Abstract: Compounds of Formula (IA) that act as 5-HT receptor ligands and their uses in the treatment of diseases linked to the activation of 5-HT2 receptors in animals are described herein.
    Type: Grant
    Filed: May 28, 2002
    Date of Patent: November 30, 2004
    Assignee: Pfizer Inc
    Inventors: Phoebe Chiang, William A. Novomisle, Willard M. Welch, Jr.
  • 5-HT receptor ligands and uses thereof
    Publication number: 20030125334
    Abstract: Compounds of Formula (IA) that act as 5-HT receptor ligands and their uses in the treatment of diseases linked to the activation of 5-HT2 receptors in animals are described herein.
    Type: Application
    Filed: June 5, 2002
    Publication date: July 3, 2003
    Inventors: Phoebe Chiang, William A. Novomisle, Willard M. Welch, Angel Guzman-Perez, Paul A. DaSilva-Jardine, Ravi S. Garigipati, Kevin K. Liu
  • Oxamic acids and derivatives as thyroid receptor ligands
    Publication number: 20030114521
    Abstract: The present invention provides novel compounds of the Formula 1
    Type: Application
    Filed: December 20, 2002
    Publication date: June 19, 2003
    Inventors: Yuan-Ching Phoebe Chiang, Robert L. Dow
  • 5-HT receptor ligands and uses thereof
    Publication number: 20030105106
    Abstract: Compounds of Formula (IA) that act as 5-HT receptor ligands and their uses in the treatment of diseases linked to the activation of 5-HT2 receptors in animals are described herein.
    Type: Application
    Filed: May 28, 2002
    Publication date: June 5, 2003
    Inventors: Phoebe Chiang, William A. Novomisle, Willard M. Welch
  • Oxamic acids and derivatives as thyroid receptor ligands
    Patent number: 6545018
    Abstract: The present invention provides novel compounds of the Formula and prodrugs thereof, geometric and optical isomers thereof, and pharmaceutically acceptable salts of such compounds, prodrugs and isomers, wherein R1-R8 and W are as described herein. Pharmaceutical compositions containing such compounds, prodrugs, isomers or pharmaceutically acceptable salts thereof, and methods, pharmaceutical compositions and kits for treating obesity, hyperlipidemia, glaucoma, cardiac arrhythmia, skin disorders, thyroid disease, hypothyroidism and related disorders and diseases such as diabetes mellitus, atherosclerosis, hypertension, coronary heart disease, hypercholesteremia, depression and osteoporosis are also provided.
    Type: Grant
    Filed: September 27, 2001
    Date of Patent: April 8, 2003
    Assignee: Pfizer Inc.
    Inventors: Yuan-Ching Phoebe Chiang, Robert L. Dow
  • Oxamic acids and derivatives as thyroid receptor ligands
    Publication number: 20020049226
    Abstract: The present invention provides novel compounds of the Formula 1
    Type: Application
    Filed: September 27, 2001
    Publication date: April 25, 2002
    Inventors: Yuan-Ching Phoebe Chiang, Robert L. Dow
  • Oxamic acids and derivatives as thyroid receptor ligands
    Patent number: 6326398
    Abstract: The present invention provides novel compounds of the Formula and prodrugs thereof, geometric and optical isomers thereof, and pharmaceutically acceptable salts of such compounds, prodrugs and isomers, wherein R1-R8 and W are as described herein. Pharmaceutical compositions containing such compounds, prodrugs, isomers or pharmaceutically acceptable salts thereof, and methods, pharmaceutical compositions and kits for treating obesity, hyperlipidemia, glaucoma, cardiac arrhythmia, skin disorders, thyroid disease, hypothyroidism and related disorders and diseases such as diabetes mellitus, atherosclerosis, hypertension, coronary heart disease, hypercholesteremia, depression and osteoporosis are also provided.
    Type: Grant
    Filed: February 28, 2000
    Date of Patent: December 4, 2001
    Assignee: Pfizer Inc.
    Inventors: Yuan-Ching Phoebe Chiang, Robert L. Dow